What is the primary objective of hemorrhage control in Tactical Combat Casualty Care (TCCC), and which device is first-line for severe extremity bleeding?

Prepare for the Army Deployed Medical Test with our comprehensive quiz. Practice with multiple choice questions complete with hints and explanations. Get ready to excel in your exam confidently!

Multiple Choice

What is the primary objective of hemorrhage control in Tactical Combat Casualty Care (TCCC), and which device is first-line for severe extremity bleeding?

Explanation:
Stopping life-threatening bleeding quickly to prevent exsanguination is the core goal of hemorrhage control in Tactical Combat Casualty Care. In the field, uncontrolled hemorrhage is the leading preventable cause of death, so the priority is to stop the bleed as fast as possible to keep the patient alive long enough to reach definitive care. For severe extremity bleeding, a tourniquet is the first-line device because it rapidly halts arterial blood flow, is effective in most cases, and can be applied even when access to the wound is difficult. Splints help with limb stabilization after bleeding is controlled, and chest seals address chest injuries, but they do not replace the need to stop life-threatening limb bleeding with a tourniquet.

Stopping life-threatening bleeding quickly to prevent exsanguination is the core goal of hemorrhage control in Tactical Combat Casualty Care. In the field, uncontrolled hemorrhage is the leading preventable cause of death, so the priority is to stop the bleed as fast as possible to keep the patient alive long enough to reach definitive care.

For severe extremity bleeding, a tourniquet is the first-line device because it rapidly halts arterial blood flow, is effective in most cases, and can be applied even when access to the wound is difficult. Splints help with limb stabilization after bleeding is controlled, and chest seals address chest injuries, but they do not replace the need to stop life-threatening limb bleeding with a tourniquet.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy